Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Makiko Mizutani"'
Autor:
Miki Yamaguchi, Hiroyuki Yasojima, Fuminori Aki, Fumie Fujisawa, Makiko Mizutani, Takahiro Nakayama, Katsuhide Yoshidome, Jun Yamamura, Junji Tsurutani, Yoshifumi Komoike, Tomomi Yamada, Hirotaka Morishima, Satoshi Morita, Mitsuhiko Iwamoto, Tsutomu Takashima, Norikazu Masuda, Masahiko Ikeda, Tetsuhiro Yoshinami
Publikováno v:
Cancer Research. 80:P3-12
Background: In the International Consensus Conference Guidelines for Advanced Breast Cancer, most experts agreed that the maintenance endocrine therapy after induction chemotherapy was reasonable. The combination therapy of bevacizumab (B) and paclit
Autor:
Noah Saederup, Astrid E Cardona, Kelsey Croft, Makiko Mizutani, Anne C Cotleur, Chia-Lin Tsou, Richard M Ransohoff, Israel F Charo
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176931 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0013693.].
Externí odkaz:
https://doaj.org/article/9f838fc6f71247af8525f2a988b1ce8e
Autor:
Makiko Mizutani, Yoko Otani, Norikazu Masuda, Hiroyuki Yasojima, Nozomi Morikawa, Misato Masuyama, Masayuki Mano, Kiyoshi Mori
Publikováno v:
Immunotherapy. 13:189-194
Rechallenge of immune checkpoint inhibitors has been reported for neoplasms other than breast cancer. Reported here is a case of a 55-year old woman diagnosed as having triple-negative right breast cancer with multiple metastases including lung. Atez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 3 (2016)
BackgroundThe adult mammalian heart responds to cardiac injury by formation of persistent fibrotic scar that eventually leads to heart failure. In contrast, the neonatal mammalian heart reacts to injury by the development of transient fibrotic tissue
Externí odkaz:
https://doaj.org/article/a1a4d82c85d34d4fbfb11e1931ff1903
Autor:
Toshimi Takano, Nobuaki Sato, Takashi Morimoto, Masakazu Toi, Satoshi Morita, Kenji Higaki, Shoichiro Ohtani, Makiko Mizutani, Tomomi Fujisawa, Nobuki Matsunami, Yasuhiro Yanagita, Norikazu Masuda, Shinji Ohno, Yutaka Yamamoto, Sachiko Tanaka-Mizuno, Koji Kaneko, Takayuki Kadoya, Masato Takahashi, Hiroshi Ishiguro
Publikováno v:
Breast Cancer Research and Treatment
Purpose Our primary objective was to determine the benefit/risk of anthracycline-free regimens by comparing docetaxel + cyclophosphamide (TC) alone, fluorouracil + epirubicin + cyclophosphamide (FEC) followed by TC, or TC followed by FEC as a primary
Autor:
Norikazu Masuda, Makiko Ono, Toru Mukohara, Hiroyuki Yasojima, Tatsunori Shimoi, Kokoro Kobayashi, Kenichi Harano, Makiko Mizutani, Maki Tanioka, Shunji Takahashi, Takahiro Kogawa, Takuya Suzuki, Shiori Okumura, Takao Takase, Reiko Nagai, Taro Semba, Zi-Ming Zhao, Min Ren, Kan Yonemori
Publikováno v:
European journal of cancer (Oxford, England : 1990). 168
A liposomal formulation of eribulin, E7389-LF, may provide improved pharmacokinetics and allow increased access to tumour tissues. This expansion of a phase 1 study assessed the safety and efficacy of E7389-LF in patients with human epidermal growth
Autor:
Miki Yamaguchi, Tomomi Yamada, Yoshifumi Komoike, Takahiro Nakayama, Mitsuhiko Iwamoto, Makiko Mizutani, Jun Yamamura, Norikazu Masuda, Katsuhide Yoshidome, Tetsuhiro Yoshinami, Hiroyuki Yasojima, Fuminori Aki, Tsutomu Takashima, Satoshi Morita, Hirotaka Morishima, Fumie Fujisawa, Junji Tsurutani, Masahiko Ikeda
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4399, p 4399 (2021)
Volume 13
Issue 17
Cancers, Vol 13, Iss 4399, p 4399 (2021)
Volume 13
Issue 17
Optimal treatment strategies for hormone receptor (HR)-positive, HER2-negative advanced and/or metastatic breast cancer (AMBC) remain uncertain. We investigated the clinical usefulness of adding capecitabine to maintenance endocrine therapy after ind
Autor:
Yusuke Yamaoka, Jun Yamamura, Norikazu Masuda, Hiroyuki Yasojima, Makiko Mizutani, Shoji Nakamori, Toru Kanazawa, Keiko Kuriyama, Masayuki Mano, Mitsugu Sekimoto
Publikováno v:
Case Reports in Medicine, Vol 2014 (2014)
Primary chest wall abscess occurring after blunt chest trauma is rare. We present the case of a 50-year-old woman who presented with a swelling in her left breast. The patient had experienced blunt chest trauma 2 months back. Needle aspiration reveal
Externí odkaz:
https://doaj.org/article/13748c9b53ac4e7ba0b1897fe13aae2c
Autor:
Jun Yamamura, Norikazu Masuda, Yoshinori Kodama, Hiroyuki Yasojima, Makiko Mizutani, Keiko Kuriyama, Masayuki Mano, Shoji Nakamori, Mitsugu Sekimoto
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Carcinoma of an accessory mammary gland is an extremely rare tumor. A 61-year-old male patient presented with a hard mass measuring 85 mm × 51 mm in the left axilla. Incisional biopsy histopathologically showed an adenocarcinoma compatible with brea
Externí odkaz:
https://doaj.org/article/688f7d9ae27a4b3cae9e2e9be5f7cde4
Autor:
Masako Sato, Hidetoshi Kawaguchi, Satoshi Morita, Makiko Mizutani, Yoshie Hasegawa, Ken-ichi Watanabe, Yasuaki Sagara, Fumikata Hara, Takashi Morimoto, Takahiro Nakayama, Norikazu Masuda, Mitsuya Itoh, Shoichiro Ohtani, Nobuki Matsunami, Kenji Higaki, Masato Takahashi, Tetsuhiro Yoshinami
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule. Methods Patients with metastatic breast cancer (MBC) treated with both anthracycline and